See more : Takashimaya Company, Limited (8233.T) Income Statement Analysis – Financial Results
Complete financial analysis of AVVAA World Health Care Products, Inc. (AVVH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AVVAA World Health Care Products, Inc., a leading company in the Shell Companies industry within the Financial Services sector.
- Taseko Mines Limited (TKO.L) Income Statement Analysis – Financial Results
- Cinevista Limited (CINEVISTA.BO) Income Statement Analysis – Financial Results
- Brookfield Renewable Partners L.P. (BEP-PK.TO) Income Statement Analysis – Financial Results
- Valartis Group AG (0RPP.L) Income Statement Analysis – Financial Results
- Stove Kraft Limited (STOVEKRAFT.NS) Income Statement Analysis – Financial Results
AVVAA World Health Care Products, Inc. (AVVH)
About AVVAA World Health Care Products, Inc.
AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.
| Metric | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 95.58K | 18.66K | 13.02K | 9.41K | 0.00 | 0.00 | 1.00 | 0.00 |
| Cost of Revenue | 444.10K | 34.72K | 6.28K | 6.20K | 0.00 | 0.00 | 3.32K | 0.00 |
| Gross Profit | -348.52K | -16.06K | 6.74K | 3.21K | 0.00 | 0.00 | -3.32K | 0.00 |
| Gross Profit Ratio | -364.65% | -86.09% | 51.79% | 34.06% | 0.00% | 0.00% | -332,000.00% | 0.00% |
| Research & Development | 157.15K | 137.76K | 269.43K | 155.69K | 26.00K | 0.00 | 112.13K | 7.28K |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 107.92K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.22K |
| SG&A | 2.63M | 2.46M | 2.32M | 1.99M | 782.98K | 80.76K | 131.30K | 112.13K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.82M | 2.62M | 2.84M | 2.15M | 810.36K | 81.60K | 244.26K | 267.53K |
| Cost & Expenses | 3.26M | 2.66M | 2.84M | 2.15M | 810.36K | 81.60K | 247.58K | 267.53K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.32M | 1.23M | 323.77K | 8.44K | 9.25K | 604.00 | 4.63K | 0.00 |
| Depreciation & Amortization | 1.17M | 1.20M | 1.41M | 6.10K | 1.39K | 832.00 | 38.33K | 832.00 |
| EBITDA | -2.01M | -1.27M | -1.19M | -1.19M | -808.98K | -200.55K | -200.55K | -209.25K |
| EBITDA Ratio | -2,102.92% | -6,815.85% | -9,161.54% | -21,904.28% | 0.00% | 0.00% | -20,924,700.00% | 0.00% |
| Operating Income | 3.16M | 2.64M | 2.83M | 2.14M | 810.36K | 81.60K | 247.58K | 267.53K |
| Operating Income Ratio | 3,311.20% | 14,133.30% | 21,729.80% | 22,795.14% | 0.00% | 0.00% | 24,758,000.00% | 0.00% |
| Total Other Income/Expenses | 17.37K | -166.04K | -31.36K | -77.72K | -77.72K | 119.79K | 165.98K | -1.00 |
| Income Before Tax | 3.18M | 2.47M | 2.61M | 2.07M | 0.00 | 201.39K | 247.58K | 0.00 |
| Income Before Tax Ratio | 3,329.37% | 13,243.36% | 20,009.92% | 21,969.09% | 0.00% | 0.00% | 24,757,900.00% | 0.00% |
| Income Tax Expense | 1.31M | 1.40M | 316.34K | 86.16K | 9.25K | -119.19K | 4.64K | 0.00 |
| Net Income | -4.47M | -4.04M | -3.15M | -2.23M | -819.61K | 37.59K | -252.22K | -267.53K |
| Net Income Ratio | -4,677.64% | -21,627.63% | -24,159.24% | -23,710.89% | 0.00% | 0.00% | -25,221,500.00% | 0.00% |
| EPS | -3.27 | -9.52 | -11.45 | -11.07 | -6.58 | 1.00 | -2.15 | -2.44 |
| EPS Diluted | -3.27 | -9.52 | -11.45 | -11.07 | -6.58 | 1.00 | -2.15 | -2.44 |
| Weighted Avg Shares Out | 1.37M | 423.95K | 274.77K | 201.56K | 124.53K | 124.53K | 117.19K | 109.76K |
| Weighted Avg Shares Out (Dil) | 1.37M | 423.95K | 274.77K | 201.56K | 124.53K | 126.41K | 117.19K | 109.76K |
Source: https://incomestatements.info
Category: Stock Reports